X4 Pharmaceuticals, Inc
XFOR· Nasdaq
X4 Pharmaceuticals, Inc
- Last sale
- Oct 1, 2026 · -2.76%
- Market cap
- $279.59M
- 99.15M shares
- Filings
- 812
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $35,113,000 | reported | |
| FY 2024 | 2024-12-31 | $2,557,000 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $0 | reported | |
| FY 2021 | 2021-12-31 | $0 | reported | |
| FY 2020 | 2020-12-31 | $3,000,000 | reported | |
| FY 2019 | 2019-12-31 | $0 | reported | |
| FY 2018 | 2018-12-31 | $0 revised | reported |
X4 Pharmaceuticals, Inc · CIK 1501697 · Engraved from SEC EDGAR
